Skip to content

Clinical trials

Phase 3 Heart Failure trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Poland Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20051
20063
20073
20081
20091
20111
20121
20131
20143
20151
20162
20176
20184
20193
20202
20222
20232
20248
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting15
Terminated7
Active, not recruiting3
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Novartis Pharmaceuticals7
AstraZeneca5
Bayer3
Novo Nordisk A/S3
Amgen2
Colorado Prevention Center2
Cytokinetics2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure58
Cardiovascular Diseases4
Coronary Artery Disease3
Heart Diseases3
Myocardial Infarction3
Stroke3
Ventricular Dysfunction, Left3
Diabetes Mellitus, Type 22
Hypertension2
Hyponatremia2

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.